FGFR2 and neoplasm: Notably, although sample sizes were small, dual FGFR2b/c expressing GCs had a significantly poorer outcome compared to GCs that only overexpressed FGFR2b, which may be due to the expanded repertoire of FGFs capable of activating FGFR2 in these tumours [22].